Log In
BCIQ
Print this Print this
 

CPX-8

  Manage Alerts
Collapse Summary General Information
Company Jazz Pharmaceuticals plc
DescriptionHydrophobic docetaxel prodrug nanoparticle
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$1,500.0M

$1,500.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/12/2016

$1,500.0M

$1,500.0M

0

Get a free BioCentury trial today